A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01217957 · COMPLETED
Trial details
- NCT number
- NCT01217957
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-22
- Primary completion
- 2013-03-08
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.